Clinical Trials
Infinity Initiates Phase 2 Trial of IPI-926 in Patients...
Infinity Pharmaceuticals, Inc. announced the initiation of a randomized, double-blind Phase 2 clinical trial to evaluate the safety and efficacy of IPI-926 compared to placebo...
Clinical Trials
NovaBay Pharmaceuticals Initiates Phase 2 Clinical Trial for the...
NovaBay Pharmaceuticals, Inc., a clinical stage biotechnology company developing its first-in-class, anti-infective Aganocide compounds for the local non-systemic treatment and prevention of antibiotic-resistant infections, today...
Clinical Trials
GlaxoSmithKline and Human Genome Sciences announce publication of BLISS-52...
GlaxoSmithKline (GSK) and Human Genome Sciences, Inc. announced publication of the BLISS-52 study of Benlysta® (belimumab) in autoantibody-positive patients with active systemic lupus erythematosus (SLE)...
Clinical Trials
Plexxikon Initiates Phase 1 Clinical Trial for Oral Rheumatoid...
Plexxikon Inc. announced that dosing began in the first of two Phase 1 clinical trials with PLX5622, a novel, oral and highly selective Fms inhibitor,...
Clinical Trials
Sanofi-aventis Reports Top-line Results from Phase III Study with...
Sanofi-aventis and its subsidiary, BiPar Sciences, announced that a randomized Phase III trial evaluating BSI-201 (iniparib*) in patients with metastatic triple-negative breast cancer (mTNBC) did...
Clinical Trials
Patients enrolled in EU Phase III Clinical Development Progam...
Bayer HealthCare’s dermatology business Intendis and KYTHERA Biopharmaceuticals, Inc. announced the initiation of two European Phase III studies evaluating ATX-101, a first-in-class injectable adipolytic agent,...
Clinical Trials
VistaGen Therapeutics Announces Successful Completion of Initial Phase 1...
VistaGen Therapeutics, Inc., a stem cell technology company focused on drug discovery and development, today announced the successful completion of its initial Phase 1 safety...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.